GOLD and the fixed ratio Source: Eur Respir J 2011; 38: 481-482 Year: 2011
GOLD and the fixed ratio Source: Eur Respir J 2011; 38: 482-484 Year: 2011
A MULTILATERAL APPROACH TO COPD COMORBIDITIES Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018
EOSINOPHIL COUNT AND FeNO AS PREDICTORS OF EXACERBACTIONS IN COPD Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018
Implications of using the fixed ratio in diagnosing COPD in the elderly Source: Annual Congress 2008 - Defining COPD using the "fixed ratio" (FEV1/FVC <0.70) – pro and con Year: 2008
BODE INDEX IN DIFFERENT PHENOTYPES OF COPD Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017
Dysinapsis in COPD and ASTHMA Source: Eur Respir J 2003; 22: Suppl. 45, 416s Year: 2003
Impact of severe exacerbations on lung function in dupilumab-treated patients: LIBERTY ASTHMA QUEST Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021
Peak inspiratory flow evaluation in different stages’ COPD patients using in-check method (INSPIRE STUDY) Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016
Neutrophil-to-lymphocyte ratio and COPD exacerbations in the TIE-study Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020
Defining the role of neutrophil-to-lymphocyte ratio in COPD patients Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020
A comparison of 129Xe MRI and advanced lung function testing in patients with asthma and /or COPD: The NOVELTY ADPro substudy Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies Year: 2021
Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort Source: Eur Respir J, 58 (3) 2003927; 10.1183/13993003.03927-2020 Year: 2021
Factors associated with exacerbations in patients with COPD: NOVELTY study Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020
Management of high risk patients with COPD, identified by the DOSE index, in general practice Source: Annual Congress 2009 - COPD case-finding and management in primary care Year: 2009
Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases Year: 2020
A comparison of the ADO, BODE and DOSE scores for predicting respiratory hospitalisations in a primary care COPD cohort Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016
ARE THERE DIFFERENCES IN EXERCISE CAPACITY BY GENDER IN COPD PATIENTES? Source: Virtual Congress 2020 – COPD phenotypes Year: 2020
Implications of under treatment of stable COPD (SAVING study) Source: International Congress 2015 – New data on established treatments for COPD Year: 2015
Distribution of T2 markers in real-life patients with asthma, COPD and asthma+COPD from the BREATHE study Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020